CAS number：875446-37-0 molecular formula：C30H25F10NO3
Anacetrapib (MK-0859)是一种有效的，选择性，可逆的rhCETP和突变CETP(C13S)抑制剂，IC50分别为7.9 nM和11.8 nM，提高HDL-C，降低LDL-C，不提高醛固酮和血压。Phase 3。A potent and selective CETP inhibitor. Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3. A potent and selective CETP inhibitor.
| Chinese alias | 安塞曲匹 | ||
| English alias | Anacetrapib - MK-0859 | s2748 | KBio3_001100 | MLS006010190 | A24886 | BDBM50348228 | STL554443 | Anacetrapib (JAN/USAN) | Anacetrapib [USAN] | SCHEMBL570008 | AS-19552 | (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-5'isopropyl-2'-methoxy-4-(t | ||
| CAS number | 875446-37-0 | molecular formula | C30H25F10NO3 |
| molecular weight | 637.51 g/mol | Exact mass | - |
| PSA | 38.800 Ų | logp | 8.8 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
